News Focus
News Focus
Followers 24
Posts 4176
Boards Moderated 0
Alias Born 12/18/2019

Re: Roman516 post# 521726

Friday, 10/14/2022 2:20:27 PM

Friday, October 14, 2022 2:20:27 PM

Post# of 822903
Regulators cared about Optune Phase 3 trial -- They all approved it and Optune is generating revenue.

Investment community isn't showing optimism for NWBO approval as the share price showed NO positive response to the TLD data.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News